Olema Pharmaceuticals Reports Q2 2026 Financial Results

What Happened
Olema Pharmaceuticals, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release furnished on Form 8-K dated August 10, 2026. The company filed the notice under Item 2.02 (Results of Operations and Financial Condition) and made the press release available as an exhibit.

Key Details

• Filing date: August 10, 2026; quarter covered: ended June 30, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition.
• Exhibit 99.1: Press Release dated August 10, 2026 was furnished with the 8-K.
• Report signed by Sean Bohen, M.D., Ph.D., President and Chief Executive Officer. (Exhibit 104: Cover Page Interactive Data File also included.)

Why It Matters
This 8-K notifies investors that Olema has released its latest quarterly results; investors should review the furnished press release (Exhibit 99.1) for specific metrics such as revenue, net income or loss, cash position and any operational updates. The filing itself does not embed the numerical results in the 8-K text, so the press release is the primary source for the detailed quarterly figures and any commentary from management.